Interestingly, some studies have described an association of FGF-23 with CV events and mortality in patients without CKD in whom the typical constellation of abnormal bone-mineral metabolism seen in CKD and ESRD is not present (88). The gene discussed is FGF23; the disease is chronic kidney disease.